Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
14,762,259
-
Share change
-
+770,728
-
Total reported value
-
$30,113,226
-
Put/Call ratio
-
186%
-
Price per share
-
$2.04
-
Number of holders
-
36
-
Value change
-
+$1,536,126
-
Number of buys
-
17
-
Number of sells
-
13
Institutional Holders of AC Immune SA - SHS (ACIU) as of Q4 2022
As of 31 Dec 2022 AC Immune SA - SHS (ACIU) had 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 14,762,259 shares of stock of the company.
Largest 10 holders included BVF INC/IL, MORGAN STANLEY, PLATINUM INVESTMENT MANAGEMENT LTD, Artal Group S.A., WELLS FARGO & COMPANY/MN, Assenagon Asset Management S.A., RENAISSANCE TECHNOLOGIES LLC, Avidity Partners Management LP, DEUTSCHE BANK AG\, and CITADEL ADVISORS LLC.
This table shows 36 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.